Latebreakers: April 3, 2006

Article

President Bush nominated acting FDA commissioner Andrew vonEschenbach, M.D., to permanently head the agency. Eschenbach, whoalso heads the National Cancer Institute, may faceconflict-of-interest charges at his confirmation hearings, andSenate Democrats have threatened to hold up his confirmation overFDA's inaction on OTC status for the emergency contraceptive PlanB. NCPA and NACDS had no comment on the Eschenbach nomination, butAPhA views him as an "excellent choice."

Recent Videos
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.